
Wednesday, April 17, 2024 9:14:46 AM
LINK
LONDON, UK / ACCESSWIRE / April 16, 2024 / Birkenstock Holding plc ("BIRKENSTOCK" or the "Company") (NYSE:BIRK), announced today the appointment of Megan Kulick to Director Investor Relations, effective April 15, 2024.
Based in New York, Ms. Kulick will report to the Board of Directors of the Company.
Oliver Reichert, CEO of the BIRKENSTOCK Group and Member of the Board of Directors of the Company: "It was extremely important for us to fill the position with an Investor Relations Professional who not only has a high reputation in the market and an excellent professional background, but also speaks the language of the Street and whom we trust to convey our unique equity story in the most credible and effective way.
Her background as an analyst, investor and IR professional positions her well to convey BIRKENSTOCK's strategies and outcomes to the investment community and other key stakeholders."
Ms. Kulick brings over 20 years of strong and international financial experience spanning investor relations, equity research, and portfolio management at top tier U.S. banks and large listed corporations. Most recently she led Investor Relations for Cresco Labs.
Prior to that she held several senior positions, including the role of Head of Investor Relations at AYR Wellness Inc., Senior Vice President at PIMCO, Director at Merrill Lynch, and VP at JPMorgan Chase. Megan began her career at Merrill Lynch in Equity Research covering Telecommunications Services.
Ms. Kulick holds a bachelor's degree in Business Administration and Finance from the University of Michigan and an MBA from the Colombia Business School.
TRUISM ENDORSED
I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of them.
Recent BIRK News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/10/2025 08:15:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/06/2025 08:32:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/06/2025 08:31:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2025 08:15:06 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/30/2025 03:02:32 PM
- Form 424B7 - Prospectus [Rule 424(b)(7)] • Edgar (US Regulatory) • 05/29/2025 05:13:30 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/29/2025 08:15:02 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/15/2025 10:03:49 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/06/2025 11:01:06 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/20/2025 11:03:06 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/20/2025 11:02:02 AM
- Form F-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 02/13/2025 09:15:36 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/21/2025 12:02:30 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/16/2025 11:01:09 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/10/2025 11:08:33 AM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/18/2024 12:02:48 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/18/2024 11:03:29 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 11:21:55 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/07/2024 11:35:03 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2024 08:15:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/12/2024 08:16:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/30/2024 08:16:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/30/2024 01:38:03 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/29/2024 10:19:44 AM
- U.S. Futures Rise; Oil Prices Dip Amid Libyan Supply Concerns and Inventory Drop • IH Market News • 08/29/2024 10:11:58 AM
FEATURED Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM
VAYK Discloses More Insider Buying Approaching 15 Million • VAYK • Jul 2, 2025 10:37 AM